"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
| Descriptor ID |
D054304
|
| MeSH Number(s) |
D06.472.334.984.500
|
| Concept/Terms |
Anti-Mullerian Hormone- Anti-Mullerian Hormone
- Anti Mullerian Hormone
- Antimullerian Hormone
- Mullerian Inhibiting Hormone
- Mullerian Inhibiting Substance
- Mullerian-Inhibitory Substance
- Mullerian Inhibitory Substance
- Mullerian-Inhibiting Factor
- Mullerian Inhibiting Factor
- Mullerian-Inhibiting Hormone
- Anti-Mullerian Factor
- Anti Mullerian Factor
- Mullerian Regression Factor
|
Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".
Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".
This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.
-
Baker VL, Glassner MJ, Doody K, Schnell VL, Gracia C, Shin SS, Behera MA, Le Saint CM, Alper MM, Pavone ME, Zbella EA, Coddington CC, Marshall LA, Feinberg RF, Cooper AR, Straseski JA, Broyles DL. Validation study of the Access antim?llerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2021 08; 116(2):575-582.
-
Sharara FI, Lelea LL, Rahman S, Klebanoff JS, Moawad GN. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. J Assist Reprod Genet. 2021 May; 38(5):1003-1012.
-
Pecker LH, Hussain S, Christianson MS, Lanzkron S. Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide. Br J Haematol. 2020 12; 191(5):880-887.
-
Tiegs AW, Sun L, Scott RT, Goodman LR. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve. Fertil Steril. 2020 04; 113(4):788-796.e4.
-
Morin SJ, Tao X, Marin D, Zhan Y, Landis J, Bedard J, Scott RT, Seli E. DNA methylation-based age prediction and telomere length in white blood cells and cumulus cells of infertile women with normal or poor response to ovarian stimulation. Aging (Albany NY). 2018 12 08; 10(12):3761-3773.
-
Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME, Behera MA, Zbella EA, Shapiro BS, Straseski JA, Broyles DL. Multicenter evaluation of the Access AMH antim?llerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018 08; 110(3):506-513.e3.
-
Olcha M, Franasiak JM, Shastri S, Molinaro TA, Congdon H, Treff NR, Scott RT. Genotypically determined ancestry across an infertile population: ovarian reserve and response parameters are not influenced by?continental origin. Fertil Steril. 2016 Aug; 106(2):475-80.
-
Henry NL, Xia R, Schott AF, McConnell D, Banerjee M, Hayes DF. Prediction of postchemotherapy ovarian function using markers of ovarian reserve. Oncologist. 2014 Jan; 19(1):68-74.
-
Hoshiya Y, Gupta V, Kawakubo H, Brachtel E, Carey JL, Sasur L, Scott A, Donahoe PK, Maheswaran S. Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells. J Biol Chem. 2003 Dec 19; 278(51):51703-12.